Background Low-density lipoprotein (LDL) cholesterol lowering is a primary goal in clinical management of patients with cardiovascular disease, but traditional cholesterol levels may not accurately reflect the true atherogenicity of plasma lipid profiles.
Patney Heather L+6 more
doaj +1 more source
A Simple Fluorescent Cholesterol Labeling Method to Cryoprotect and Detect Plasma Lipoprotein-X. [PDF]
Neufeld EB+6 more
europepmc +1 more source
Human plasma lipoproteinsIII. The effect of bilateral oophorectomy on the plasma lipoproteins in young women with advanced mammary carcinoma [PDF]
Marion Barclay+5 more
openalex +1 more source
Advanced Pharmaceutical Nanotechnologies Applied for Chinese Herbal Medicines
This review offers a comprehensive overview of pharmaceutical nanotechnology strategies to address limitations associated with the complex material basis and relative mild therapeutic efficacy of Chinese herbal medicines, and summarizes the advantages of these strategies.
Jiameng Li+11 more
wiley +1 more source
Dimeric lipoprotein lipase is bound to triglyceride-rich plasma lipoproteins
Lipoprotein lipase hydrolyzes the triglyceride-rich core of chylomicrons and very low density lipoproteins. It is also a ligand, in vitro, for binding of lipoproteins to the low density lipoprotein receptor-related protein and may play a central role in ...
A Zambon+3 more
doaj
Recurrent Embolic Strokes of Undetermined Source in a Patient with Extreme Lipoprotein(a) Levels
Lipoprotein(a) is a plasma lipoprotein and known cardiovascular risk factor most recently implicated in the development of high-risk carotid atherosclerotic plaques without significant carotid stenosis.
Zachary Bulwa+4 more
doaj +1 more source
Plasma lipoprotein (a) and tissue plasminogen activator are associated with increased risk of atherosclerotic cardiovascular disease. [PDF]
Mayyas F, Bani Omar E.
europepmc +1 more source
Post‐Translational Modified Neoantigens in Autoimmune Diseases: Challenges of Immune Tolerance
Autoimmune diseases have a high incidence and disability rate. The pathogenesis of autoimmune diseases involves the interaction among genetic factors, environmental factors, and immune disorders. The post‐translational modified neoantigens are the key nodal of these three factors. And these post‐translational modified neoantigens, after being presented
Yue Zhai+5 more
wiley +1 more source
Plasma Lipoprotein(a) Levels as Determinants of Arterial Stiffening in Hypertension. [PDF]
Brosolo G+8 more
europepmc +1 more source
Relation between endogenous lipoprotein lipase activity, free fatty acids, and glucose in plasma of women in labour and of their newborns. [PDF]
C. T. Gürson, L. Etili, S. Soyak
openalex +1 more source